SFX

1.69%

29.0¢ sheffield resources limited

Hey 2ic, love your commentary and analysis when it comes to SFX....

First 67 Last

Share
Profile

Follow
BearRaider

66 Posts.

15

11/08/20

13:48

Post #: 46453971
Share

Originally posted by 2ic: ↑

I think SFX is good buying around 30c short and longer term. It's great to do a deal but it's not a great deal really. SFX is selling 50% of TB for A$65M which is a lot less than early expectations were guided. It's certainly half of expectations from Jan 2019.

Short term we have so many profit takers and stale holders for which getting their money back after averaging down into Feb-Mar smashing is a gift that can't help but accept. Something cathartic about going from deep underwater to being made whole and money safely back in the bank. FIRB and the delay is a no news holding pattern the market hates, so many who like th story will be wondering why rush in now unless it's going to settle higher shortly. Which it might, depends on the bigger funds and whether they like the story and want to take a position. It won;t be old holders like us soaking up the sellers and riving up the share price obviously.

SFX have been playing this new BFS close to their chest, so I have no idea how it's going to look. Capex won;t drop by as much as we were guided and neither will opex bringing back the LTR. Pricing will be better per unit of TiO2 with a LTR product, hopefully enough to cover the reduction is revenue selling an unprocessed Zr-rich con.

After previous failures and heavy selling into the sizzle of BFSU great new thang one would think the market leary of chasing SFX anywhere much. Memories of great news failing to deliver results in the end will probably dog the stock and keep it too cheap to sell. Just a shame that past failures means that 30c is now seen as a sell to many even after a funding JV is announced. A lot of dead bodies to chop through on the way back up from here, going to take time.

Expand

Hey 2ic, love your commentary and analysis when it comes to SFX. Could you explain the $65m for 50% of the project. I read it as $130m for 50% of the project, I may have read it wrong though.

Thanks.

SFX Price at posting: 32.0¢ Sentiment: Hold Disclosure: Held
Upvote

0 Great analysis

Reply

Top Stories

RCE

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

BCI

BCI reaches close of funding facility for salt-first part of Mardie project

NTI

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

ACW

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

BUX

Buxton projects new graphite province discovery at WA Narryer play

CKA

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

SLS

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

COD

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

WCN

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

There are more pages in this discussion • 87 more messages in this thread...

First 67 Last

Add SFX (ASX) to my watchlist

(20min delay)
Last 29.0¢		Change -0.005(1.69%)		Mkt cap ! $114.4M

Open	High	Low	Value	Volume
30.0¢	30.0¢	29.0¢	$29.46K	100.6K

Buyers (Bids)

No.	Vol.	Price($)
4	32700	29.0¢

Sellers (Offers)

Price($)	Vol.	No.
30.5¢	5312	1

View Market Depth

No.	Vol.	Price($)
4	32700	0.290
3	7931	0.285
2	10810	0.280
1	50000	0.275
2	38000	0.270

Price($)	Vol.	No.
0.305	5312	1
0.310	16129	1
0.320	107149	4
0.330	40000	1
0.340	22022	1

Last trade - 10.43am 04/10/2024 (20 minute delay)

SFX (ASX) Chart

Hey 2ic, love your commentary and analysis when it comes to SFX....

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

BCI reaches close of funding facility for salt-first part of Mardie project

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Buxton projects new graphite province discovery at WA Narryer play

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Hey 2ic, love your commentary and analysis when it comes to SFX....

Top Stories

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

BCI reaches close of funding facility for salt-first part of Mardie project

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Buxton projects new graphite province discovery at WA Narryer play

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News